Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice.

Li T, Lan JQ, Boison D.

Neuron Glia Biol. 2008 May;4(2):91-9. doi: 10.1017/S1740925X09990135. Epub 2009 Aug 13.

2.

A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance.

Shen HY, Li T, Boison D.

Epilepsia. 2010 Mar;51(3):465-8. doi: 10.1111/j.1528-1167.2009.02248.x. Epub 2009 Aug 8.

3.

Adenosine A2A receptor deficient mice are partially resistant to limbic seizures.

El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Sep;380(3):223-32. doi: 10.1007/s00210-009-0426-8. Epub 2009 Jun 2.

PMID:
19488739
4.

Pannexin 1: the molecular substrate of astrocyte "hemichannels".

Iglesias R, Dahl G, Qiu F, Spray DC, Scemes E.

J Neurosci. 2009 May 27;29(21):7092-7. doi: 10.1523/JNEUROSCI.6062-08.2009.

5.

Antiepileptic effects of silk-polymer based adenosine release in kindled rats.

Szybala C, Pritchard EM, Lusardi TA, Li T, Wilz A, Kaplan DL, Boison D.

Exp Neurol. 2009 Sep;219(1):126-35. doi: 10.1016/j.expneurol.2009.05.018. Epub 2009 May 19.

6.

Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Boison D.

Epilepsy Res. 2009 Aug;85(2-3):131-41. doi: 10.1016/j.eplepsyres.2009.03.019. Epub 2009 May 9. Review.

7.

Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans.

Löscher W.

Eur J Pharmacol. 2009 May 21;610(1-3):1-11. doi: 10.1016/j.ejphar.2009.03.025. Epub 2009 Mar 16. Review.

PMID:
19292981
8.

Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor knockout mice with microarray profiling.

Yu L, Coelho JE, Zhang X, Fu Y, Tillman A, Karaoz U, Fredholm BB, Weng Z, Chen JF.

Physiol Genomics. 2009 May 13;37(3):199-210. doi: 10.1152/physiolgenomics.90353.2008. Epub 2009 Mar 3.

9.

Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus.

Etherington LA, Patterson GE, Meechan L, Boison D, Irving AJ, Dale N, Frenguelli BG.

Neuropharmacology. 2009 Feb;56(2):429-37. doi: 10.1016/j.neuropharm.2008.09.016. Epub 2008 Oct 10.

PMID:
18957298
10.

The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.

Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM; Protect Steering Committee, Investigators, and Coordinators.

J Card Fail. 2008 Oct;14(8):631-40. doi: 10.1016/j.cardfail.2008.08.010. Epub 2008 Sep 14.

PMID:
18926433
11.

Adenosine as an endogenous regulating factor of hippocampal sharp waves.

Wu C, Wong T, Wu X, Sheppy E, Zhang L.

Hippocampus. 2009 Feb;19(2):205-20. doi: 10.1002/hipo.20497.

PMID:
18785213
12.

Adenosine dysfunction in astrogliosis: cause for seizure generation?

Li T, Quan Lan J, Fredholm BB, Simon RP, Boison D.

Neuron Glia Biol. 2007 Nov;3(4):353-66. doi: 10.1017/S1740925X0800015X.

13.

How do seizures stop?

Lado FA, Moshé SL.

Epilepsia. 2008 Oct;49(10):1651-64. doi: 10.1111/j.1528-1167.2008.01669.x. Epub 2008 May 21. Review.

14.

Nutritional supplements, foods, and epilepsy: is there a relationship?

Asadi-Pooya AA, Mintzer S, Sperling MR.

Epilepsia. 2008 Nov;49(11):1819-27. doi: 10.1111/j.1528-1167.2008.01678.x. Epub 2008 May 21.

15.

Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine.

El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM.

Neuropharmacology. 2008 Jul;55(1):35-40. doi: 10.1016/j.neuropharm.2008.04.007. Epub 2008 Apr 18.

PMID:
18486156
16.

Connexin 43 hemichannels are permeable to ATP.

Kang J, Kang N, Lovatt D, Torres A, Zhao Z, Lin J, Nedergaard M.

J Neurosci. 2008 Apr 30;28(18):4702-11. doi: 10.1523/JNEUROSCI.5048-07.2008.

17.

Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture.

Nagarkatti N, Deshpande LS, DeLorenzo RJ.

Neurosci Lett. 2008 May 16;436(3):289-93. doi: 10.1016/j.neulet.2008.02.076. Epub 2008 Mar 21.

18.

Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.

Cunha RA.

Purinergic Signal. 2005 Jun;1(2):111-34. doi: 10.1007/s11302-005-0649-1. Epub 2005 Mar 17.

19.

Theophylline-associated seizures and their clinical characterizations.

Korematsu S, Miyahara H, Nagakura T, Suenobu S, Izumi T.

Pediatr Int. 2008 Feb;50(1):95-8. doi: 10.1111/j.1442-200X.2007.02524.x.

PMID:
18279214
20.

The adenosine kinase hypothesis of epileptogenesis.

Boison D.

Prog Neurobiol. 2008 Mar;84(3):249-62. doi: 10.1016/j.pneurobio.2007.12.002. Epub 2007 Dec 23. Review.

Supplemental Content

Support Center